Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 1 of 114

  1. ,4-diaminopyridine

    Ultragenyx UK Limited

    Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

    phase 3 small molecule completed

    1 trial

  2. -

    Disc Medicine

    Resectable colorectal rectal metastases without extrahepatic disease

    phase 3 small molecule active

    1 trial

  3. -, Rozanolixizumab

    Lacuna Pharma Pty Ltd

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  4. -, Rozanolixizumab

    Lacuna Pharma Pty Ltd

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  5. 0.05% Voclosporin Ophthalmic Solution (VOS)

    Aurinia Pharmaceuticals

    Dry Eye Syndrome

    phase 3 small molecule completed

    1 trial

  6. 0.2 mg/kg ketamine

    United Therapeutics Europe Ltd

    Depression

    phase 3 small molecule terminated

    1 trial

  7. 0.454% stannous fluoride

    Colgate Oral Care

    Oral Malodor

    phase 3 small molecule completed

    1 trial

  8. 0.454% stannous fluoride

    Colgate Oral Care

    Calculus, Dental

    phase 3 small molecule completed

    1 trial

  9. 0.9% Sodium Chloride Solution, Glenzocimab

    Pari Pharma GmbH

    Acute ischemic stroke

    phase 3 small molecule active

    1 trial

  10. 0.9% Sodium Chloride, JNJ-78901563

    Xian-Janssen Pharmaceutical

    Invasive Extraintestinal Pathogenic Escherichia coli Disease

    phase 3 small molecule active

    1 trial

  11. 0.9% sodium chloride, GB-0895

    Generate Biomedicines

    severe uncontrolled asthma

    phase 3 small molecule active

    1 trial

  12. 0.9% sodium chloride, Lepodisiran

    Eli Lilly Co.

    Atherosclerotic Cardiovascular Disease Elevated lp(a)

    phase 3 small molecule active

    1 trial

  13. 000434

    Ferring Pharmaceuticals

    High-risk Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ(CIS) with or without papillary tumours

    phase 3 small molecule active

    1 trial

  14. 01-13

    Apimeds Pharmaceuticals US

    Osteoarthritis of the Knee

    phase 3 mab completed

    1 trial

  15. 021FSGS16010

    Travere Therapeutics

    Focal segmental glomerulosclerosis (FSGS)

    phase 3 small molecule active

    1 trial

  16. 021IGAN17001

    Travere Therapeutics

    Immunoglobulin A Nephropathy (IgAN)

    phase 3 small molecule active

    1 trial

  17. 040201

    Takeda

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  18. 042011

    The George Institute

    Langerhans Cell Histiocytosis

    phase 3 small molecule active

    1 trial

  19. 0600-PG-PSC-218

    Lacuna Pharma Pty Ltd

    Allergic rhinoconjunctivitis with or without controlled asthma

    phase 3 small molecule active

    1 trial

  20. 060018-PG-PSC-217

    Lacuna Pharma Pty Ltd

    Allergic rhinoconjunctivitis with or without asthma due to clinically relevant sensitisation to grass and olive pollen.

    phase 3 small molecule active

    1 trial

  21. 060103

    Takeda

    Hemophilia A

    phase 3 mab completed

    1 trial

  22. 060401

    Takeda

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  23. 061002

    Takeda

    Hemophilia A

    phase 3 mab terminated

    1 trial

  24. 071102

    Baxalta Innovations GmbH

    Hereditary severe von Willebrand Disease in children

    phase 3 small molecule active

    1 trial

  25. 0796-19

    Lacuna Pharma Pty Ltd

    Menière's disease

    phase 3 small molecule active

    1 trial

  26. 09

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukaemia

    phase 3 small molecule active

    1 trial

  27. 090701

    Baxalta Innovations GmbH

    Hemophilia A or B With Inhibitors

    phase 3 mab completed

    1 trial

  28. 090701

    Takeda

    Hemophilia A or B With Inhibitors

    phase 3 mab completed

    1 trial

  29. 1 apical pleurectomy

    Hospital Authority, Hong Kong

    Pneumothorax

    phase 3 other active

    1 trial

  30. 1% Clascoterone Cream

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  31. 1.0% C31G SAVVY vaginal gel

    United Therapeutics Europe Ltd

    HIV Infections

    phase 3 small molecule active

    2 trials

  32. 1.0mg/kg/day PRAX-562

    Chongqing Precision Biotech Co., Ltd

    Developmental and Epileptic Encephalopathy 1

    phase 3 small molecule active

    1 trial

  33. 10-week smoking cessation group therapy combined with NicoDerm CQ

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 3 other completed

    1 trial

  34. 100-006

    Cardiol Therapeutics

    Recurrent Pericarditis

    phase 3 small molecule active

    1 trial

  35. 1001

    Biotest Pharma GmbH

    Non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19)

    phase 3 small molecule active

    1 trial

  36. 101380003SA

    Santen Oy

    Acquired Blepharoptosis

    phase 3 small molecule active

    1 trial

  37. 104317

    GlaxoSmithKline

    Hypereosinophilic Syndrome

    phase 3 other active

    1 trial

  38. 105MS306

    Biogen

    Relapsing Remitting Multiple Sclerosis (RRMS)

    phase 3 small molecule active

    1 trial

  39. 111-302

    BioMarin Pharmaceutical Australia Pty Ltd

    Achondroplasia

    phase 3 small molecule active

    1 trial

  40. 111-303

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 3 small molecule active

    1 trial

  41. 111-308

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 3 small molecule active

    1 trial

  42. 115747

    Disc Medicine

    Metastatic renal cell carcinoma

    phase 3 small molecule active

    1 trial

  43. 116130

    Disc Medicine

    Parkinson's disease

    phase 3 small molecule active

    1 trial

  44. 1199-0378

    Boehringer Ingelheim

    Childhood Interstitial Lung Disease

    phase 3 small molecule active

    1 trial

  45. 11C-SB207145, 11C-DASB

    The George Institute

    Parkinson's disease, Prodromal phase of Parkinson's disease

    phase 3 small molecule active

    1 trial

  46. 12-Valent Pneumococcal Conjugate Vaccine

    MAIA Biotechnology

    Pneumococcal Vaccines

    phase 3 mab active

    1 trial

  47. 1245-0256

    Boehringer Ingelheim

    Chronic kidney disease in paediatric patients

    phase 3 small molecule active

    1 trial

  48. 1305-0023

    Boehringer Ingelheim

    Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.